Guidance for Industry Adaptive Design Clinical Trials for Drugs and Biologics DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments…

Slide 1Janet Woodcock, MD Director, Center for Drug Evaluation and Research Food and Drug Administration Todays Biomedical Innovation: Lost in Translation? QB3 Entrepreneurs…

1.Serious Adverse Events Associated with use of the Anti-TNF alpha Drugs William B. Tauber, M.D.Division of Therapeutic Biologic Internal Medicine Products Center for Drug…

1. Guidance for Industry Expedited Programs for Serious Conditions – Drugs and Biologics U.S. Department of Health and Human Services Food and Drug Administration Center…

1. Guidance for Industry Product Development Under the Animal Rule DRAFT GUIDANCE This guidance document is being distributed for comment purposes only Comments and suggestions…

Guidance for Industry Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention DRAFT GUIDANCE This guidance document is being distributed…

Guidance for Industry Bioanalytical Method Validation DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding…

Guidance for Industry Bioanalytical Method Validation DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding…

Slide 1 Environmental Assessments Human and Animal Drugs Nancy Sager Center for Drug Evaluation and Research Food and Drug Administration Slide 2 Statutory Framework Federal…